Validation of Esaso Classification of Diabetic Maculopathy

Eur J Ophthalmol. 2024 Mar;34(2):497-501. doi: 10.1177/11206721231186649. Epub 2023 Jul 16.

Abstract

Purpose: To test reliability and reproducibility of ESASO morphologic OCT-based classification of diabetic maculopathy (DM).

Methods: This is a multi-center cross-sectional study including a coordination center (CC) and 18 participating centers (PCs). After instruction on the correct use of ESASO Classification, the validation process was carried out in two consecutive stages. In the first retrospective phase, we evaluated the concordance between PCs and CC in the staging of OCT images collected during PCs' daily activity (608 images). In a second prospective phase, we analyzed the inter-observer agreement of staging assigned by each PCs to OCT images selected by the CC (22 images).

Results: The overall concordance achieved in the retrospective phase was 89.8% (Kappa = 0.83 (95% CI: 0.78-0.87); p<0.0001). In 99.5% of cases, concordance did not differ by more than one stage. In the prospective phase, PCs reached an inter-operator agreement of 93.0% (Krippendorff's Alpha = 0.953, 95% CI: 0.929-0.977, p<0.0001). Any discrepancy among the 22 images was within one stage.

Conclusion: The results achieved in this study confirm that ESASO OCT-based Classification can be considered as an easy and reproducible method to stage DM during clinical practice. A diffused use of a common and validated method to describe the progression of retinal damage in DM may offer several clinical and scientific advantages.

Keywords: ESASO classification; diabetic macular edema (DME); diabetic maculopathy (DM); optical coherence tomography.

MeSH terms

  • Cross-Sectional Studies
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / diagnosis
  • Humans
  • Macular Degeneration*
  • Prospective Studies
  • Reproducibility of Results
  • Retrospective Studies
  • Tomography, Optical Coherence / methods